RxDoctor Payments Data

Tyler Voss, DO

Family Medicine · Muskegon, MINPI 1346506318

Payments from drug & device makers

$527in general payments, 2019–2025

Across 13 payments — averaging $40.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$169
  • Bioventus LLC$146
  • Trice Medical, Inc.$54
  • Vertex$39
  • Amgen$38
  • Intersect ENT, Inc.$33
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$51999%
  • Education$71%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$527 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$1,087,244
Medicare patients
697
Services billed
72,852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TymlosAbaloparatide64$200,871
Teriparatide13$29,502
Evenity (2 Syringes)Romosozumab-Aqqg11$25,323
Diclofenac Sodium348$1,877
Baclofen243$1,520
Raloxifene Hcl19$663
Unifine Pentips PlusPen Needle, Diabetic49$616
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen152$569
Prednisone220$494
Celecoxib46$450
Pregabalin47$443
Ketorolac Tromethamine24$380
Alendronate Sodium51$355
Gabapentin35$227
Meloxicam48$142

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$169$200,87164 claims
AmgenEvenity (2 Syringes)$38$25,32311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →